Marie Scully

16.7k total citations · 5 hit papers
185 papers, 7.7k citations indexed

About

Marie Scully is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Marie Scully has authored 185 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Immunology, 110 papers in Hematology and 74 papers in Genetics. Recurrent topics in Marie Scully's work include Complement system in diseases (139 papers), Platelet Disorders and Treatments (69 papers) and Renal Diseases and Glomerulopathies (50 papers). Marie Scully is often cited by papers focused on Complement system in diseases (139 papers), Platelet Disorders and Treatments (69 papers) and Renal Diseases and Glomerulopathies (50 papers). Marie Scully collaborates with scholars based in United Kingdom, United States and France. Marie Scully's co-authors include Samuel J. Machin, Flora Peyvandi, Beverley J. Hunt, Marcel Levi, Sylvia Benjamin, Vickie McDonald, Ian Mackie, Will Lester, Johanna A. Kremer Hovinga and Ri Liesner and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Marie Scully

172 papers receiving 7.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination

2021 656 citations Marie Scully, Deepak Singh et al. profile →
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura

2019 602 citations Marie Scully, Spero R. Cataland et al. profile →
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies

2012 553 citations Marie Scully, Sylvia Benjamin et al. British Journal of Haematology profile →
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura

2016 429 citations Flora Peyvandi, Marie Scully et al. profile →
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis

2021 364 citations Marie Scully, Will Lester et al. profile →

Peers

Countries citing papers authored by Marie Scully

Since Specialization

Citations

This map shows the geographic impact of Marie Scully's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Scully with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Scully more than expected).

Fields of papers citing papers by Marie Scully

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Scully. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Scully. The network helps show where Marie Scully may publish in the future.

Co-authorship network of co-authors of Marie Scully

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Scully. A scholar is included among the top collaborators of Marie Scully based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Scully. Marie Scully is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term follow-up outcomes in congenital thrombotic thrombocytopenic purpura 2025 ·Blood ·Matthew Stubbs, (unknown), Prabhu Gounder, Matthew Carter, Will Lester, Alice Taylor, Amanda Clark, Will Thomas, Tina Dutt, (unknown), Joost J. van Veen, Rachel Evans, Jayanthi Alamelu, Michael Desborough, John‐Paul Westwood, Marie Scully	0
2	Caplacizumab in pediatric immune thrombotic thrombocytopenic purpura: the UK TTP Registry experience 2024 ·Blood Advances ·A. E. Taylor, (unknown), (unknown), Tina Dutt, John D. Grainger, (unknown), (unknown), Michael Richards, (unknown), (unknown), (unknown), Marie Scully	6
3	A randomised controlled trial of plasma exchange compared to standard of care in the treatment of severe COVID-19 infection (COVIPLEX) 2024 ·Scientific Reports ·Nishkantha Arulkumaran, Mari Thomas, Matthew C. Stubbs, (unknown), (unknown), Deepak Singh, Gareth Ambler, (unknown), Mervyn Singer, David Brealey, Marie Scully	1
4	Etiology and outcomes: Thrombotic microangiopathies in pregnancy 2023 ·Research and Practice in Thrombosis and Haemostasis ·Marie Scully, (unknown)	8
5	Alterations in the von Willebrand factor/ADAMTS-13 axis in preeclampsia 2023 ·Journal of Thrombosis and Haemostasis ·(unknown), Mari Thomas, Rens de Groot, Andrew J. Doyle, Deepak Singh, George W. Adams, Anna L. David, (unknown), Marie Scully	2
6	P1612: CALPROTECTIN LEVELS ARE ELEVATED IN CONGENITAL TTP AND IMMUNE TTP AT ADAMTS13 RELAPSE 2023 ·HemaSphere ·(unknown), (unknown), Marie Scully, Rens de Groot	1
7	Analysis of thrombogenicity under flow reveals new insights into the prothrombotic state of patients with post-COVID syndrome 2023 ·Journal of Thrombosis and Haemostasis ·(unknown), (unknown), Rens de Groot, (unknown), Melissa Heightman, Toby Hillman, Laura Price, (unknown), (unknown), Karen Vanhoorelbeke, Deepak Singh, Marie Scully	14
8	Pregnancy-Related Outcomes in Patients with Congenital Thrombotic Thrombocytopenic Purpura: Post Hoc Analysis of a Retrospective Chart Review Study 2023 ·Blood ·Paul Coppo, Marie Scully, Johanna A. Kremer Hovinga, (unknown), Parth Patwari, Linda T. Wang, Björn Mellgård, (unknown), (unknown)	0
9	Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy 2022 ·Blood ·Andrew J. Doyle, Matthew Stubbs, Tina Dutt, Will Lester, Will Thomas, (unknown), (unknown), Tanya Cranfield, Quentin A. Hill, Amanda Clark, Catherine Bagot, Steve Austin, John‐Paul Westwood, Mari Thomas, Marie Scully	10
10	Long‐term follow‐up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post‐HERCULES study 2022 ·Journal of Thrombosis and Haemostasis ·Marie Scully, Javier de la Rubia, (unknown), Ara Metjian, Paul Knöbl, Flora Peyvandi, Spero R. Cataland, Paul Coppo, Johanna A. Kremer Hovinga, (unknown), (unknown), Filip Callewaert, Sriya Gunawardena, Julie Lin	14
11	Pitfalls in Diagnosing Thrombotic Thrombocytopenic Purpura in Sickle Cell Disease 2022 ·Journal of Clinical Medicine ·Dimitris A. Tsitsikas, (unknown), (unknown), Jori E. May, Radhika Gangaraju, Marisa B. Marques, Marie Scully	1
12	Anti‐PF4 testing for vaccine‐induced immune thrombocytopenia and thrombosis (VITT): Results from a NEQAS, ECAT and SSC collaborative exercise in 385 centers worldwide 2022 ·Journal of Thrombosis and Haemostasis ·(unknown), Ian Jennings, Steve Kitchen, Michael Makris, Piet Meijer, Moniek P.M. de Maat, Marie Scully, Tamam Bakchoul, Isobel D. Walker	6
13	Thrombus Distribution in Vaccine-induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination 2022 ·Radiology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ali Shah, (unknown), Andrew G. Murchison, Matthew Benger, (unknown), Puja R. Mehta, L. Sztriha, (unknown), Brian Craven, Marie Scully, Timothy Bray, Margaret Hall‐Craggs, (unknown), (unknown)	9
14	Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis 2021 ·Blood Advances ·Flora Peyvandi, Spero R. Cataland, Marie Scully, Paul Coppo, Paul Knoebl, Johanna A. Kremer Hovinga, Ara Metjian, Javier de la Rubia, Katerina Pavenski, (unknown), Hilde De Winter, Filip Callewaert	50
15	Neuro-ophthalmic complications with ChAdOx1 nCoV-19 vaccine-induced thrombocytopenia and thrombosis 2021 ·British Journal of Hospital Medicine ·Victoria Nowak, Marie Scully, Indran Davagnanam, Fion Bremner	1
16	Redefining outcomes in immune TTP: an international working group consensus report 2021 ·Blood ·Adam Cuker, Spero R. Cataland, Paul Coppo, Javier de la Rubia, Kenneth D. Friedman, (unknown), Paul Knoebl, Johanna A. Kremer Hovinga, Bernhard Lämmle, Masanori Matsumoto, Katerina Pavenski, Flora Peyvandi, Kazuya Sakai, Ravi Sarode, (unknown), Yoshiaki Tomiyama, Agnès Veyradier, John‐Paul Westwood, Marie Scully	121
17	Clinical outcomes and risk factors for severe COVID‐19 in patients with haematological disorders receiving chemo‐ or immunotherapy 2020 ·British Journal of Haematology ·Thomas A. Fox, (unknown), Amy A. Kirkwood, (unknown), James Day, Selina J Chavda, Emil Kumar, (unknown), (unknown), Emilie Sanchez, Marie Scully, Asim Khwaja, Jonathan Lambert, Mervyn Singer, Claire Roddie, Emma Morris, Kwee Yong, Kirsty Thomson, Kirit M. Ardeshna	49
18	Long-Term Safety and Efficacy of Sutimlimab in Patients with Chronic Immune Thrombocytopenia 2020 ·Blood ·Catherine M. Broome, Alexander Röth, David J. Kuter, Marie Scully, Roy E. Smith, Jennifer Wang, Xiaoyu Jiang, Caroline Reuter, Ahmed Daak, William E. Hobbs	12
19	Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura 2016 ·British Journal of Haematology ·Christopher J. Patriquin, Mari Thomas, Tina Dutt, Siobhan McGuckin, Piers Blombery, Tanya Cranfield, (unknown), Marie Scully	60
20	Thrombotic thrombocytopenic purpura precipitated by acute pancreatitis: a report of seven cases from a regional UK TTP registry 2008 ·British Journal of Haematology ·Vickie McDonald, Michael Laffan, Sylvia Benjamin, David Bevan, Samuel J. Machin, Marie Scully	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact